Literature DB >> 8338619

Oral Candida in HIV infection and AIDS: new perspectives/new approaches.

D C Coleman1, D E Bennett, D J Sullivan, P J Gallagher, M C Henman, D B Shanley, R J Russell.   

Abstract

Oral candidosis has become an increasingly important problem in HIV-infected individuals. At present, the small body of published literature on the characterization of the Candida strains and species found in HIV+ patients is full of confusion and contradictions. Some of these difficulties are the result of the methodological shortcomings of a number of the techniques that have been used. Examples of the problems that may be encountered on primary isolation and subculture are described and the drawbacks associated with the systems used to date for phenotyping Candida are quoted. While molecular characterization techniques would appear to offer a reliable and objective alternative, they too have their strengths and weaknesses. An attempt is made to summarize the progress that has been made recently in the detection and identification of Candida albicans and also the non-albicans species from HIV-infected individuals. What emerges is that the commensal Candida species that inhabit the oral cavities of HIV+ patients are subjected to a number of significant pressures that probably promote the selection of organisms with unusual phenotypes and genotypes. These Candida are more difficult to characterize and behave differently compared to their counterparts in HIV- individuals. It is clear that uncovering the factors that are important for the selection of treatment regimens and will be predictive of outcome will not be easy. Candida organisms are neither as benign nor as simple as once thought.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338619     DOI: 10.3109/10408419309113523

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  35 in total

Review 1.  Microbial adhesion in flow displacement systems.

Authors:  Henk J Busscher; Henny C van der Mei
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.

Authors:  Viswanatha Krishnakumari; Nandini Rangaraj; Ramakrishnan Nagaraj
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

3.  Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications.

Authors:  Jingsong Zhu; Paul W Luther; Qixin Leng; A James Mixson
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Detection of Candida dubliniensis in Venezuela.

Authors:  Claudia Hartung de Capriles; Sofía Mata-Essayag; Celina Pérez; Maria Teresa Colella; Arantza Roselló; Carolina Olaizola; Sylvia Magaldi Teresa Abate
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

Review 5.  Oral candidiasis, HIV, and saliva glucocorticoids.

Authors:  C O Enwonwu; V I Meeks
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.

Authors:  K C Hazen; J G Wu; J Masuoka
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa.

Authors:  Elaine Blignaut; Claude Pujol; Shawn Lockhart; Sophie Joly; David R Soll
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

8.  Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting.

Authors:  A Casadevall; E D Spitzer
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

9.  Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates.

Authors:  B Posteraro; M Sanguinetti; G D'Amore; L Masucci; G Morace; G Fadda
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

10.  Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.

Authors:  Natalya U Makarova; V V Pokrowsky; A V Kravchenko; L V Serebrovskaya; Michael J James; Michael M McNeil; Brent A Lasker; David W Warnock; Errol Reiss
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.